Philippines gives green light to trials of Janssen’s COVID-19 vaccine

December 29, 2020 - 2:55 PM
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. (Reuters/Dado Ruvic/Illustration)

MANILA — The Philippines has approved a clinical trial for the COVID-19 vaccine of Johnson & Johnson’s unit Janssen, the head of its Food and Drug Administration (FDA) said on Tuesday.

The trials could begin in the next few weeks, FDA head Rolando Enrique Domingo told a media briefing.

The FDA is still evaluating the late-stage trial applications of Sinovac and Clover, Domingo said. —Reporting by Karen Lema; Editing by Martin Petty